Showing results (111-120 of 439) with videos related to

Sort By:
Pageof 44
Arthritis and Rheumatism|May 1, 2007
Mycobacterial Hsp65-IgG-expressing tolerogenic B cells confer protection against adjuvant-induced arthritis in Lewis ratsShailesh R Satpute, Nadejda Soukhareva, David W Scott, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2018
Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T CellsAi-Hong Zhang, Jeongheon Yoon, Yong Chan Kim, et al.
Frontiers in Microbiology|August 4, 2011
B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for ToleranceYan Su, Ai-Hong Zhang, Nancy Noben-Trauth, et al.
British Journal of Haematology|July 17, 2021
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic featuresJennifer R Chapman, Alyssa C Bouska, Weiwei Zhang, et al.
NAR Cancer|October 23, 2020
Activation-induced cytidine deaminase localizes to G-quadruplex motifs at mutation hotspots in lymphomaYing-Zhi Xu, Piroon Jenjaroenpun, Thidathip Wongsurawat, et al.
Neurology Research International|September 24, 2011
Potential application of tregitopes as immunomodulating agents in multiple sclerosisWassim Elyaman, Samia J Khoury, David W Scott, et al.
European Journal of Immunology|August 26, 2003
B cell receptor signaling mediates immediate protection from Fas-induced apoptosis upstream of caspase activation through an atypical protein kinase C isozyme and de novo protein synthesisJennifer A Hinshaw, Carolyn M Mueller, David W Scott, et al.
The Journal of Biological Chemistry|September 14, 2011
Endothelial surface N-glycans mediate monocyte adhesion and are targets for anti-inflammatory effects of peroxisome proliferator-activated receptor γ ligandsBalu K Chacko, David W Scott, Robert T Chandler, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 31, 2012
Tolerance induction via B-cell delivered gene therapyRobert J Rossi, Belinda M Jackson, Ai-Hong Zhang, et al.
American Journal of Hematology|December 22, 2017
A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806Daniel O Persky, Hongli Li, Lisa M Rimsza, et al.
Pageof 44